VITAMIN C PLUS CHEMOTHERAPY DOUBLES SURVIVAL in METASTATIC PANCREATIC CANCER
by Dr Simone | Dec 22, 2024 | Antioxidants, Cancer, Cancer and Nutrition, Health Policy, Healthcare, Healthcare Costs, HEALTHCARE CRISIS, Inflammation, Linus Pauling PhD, VITAMINS |
We do not diagnose disease or recommend a treatment protocol or dietary supplement for the treatment of disease. You should share this information with your physician who can determine what nutrition and disease treatment regimen is best for you. Ask your physician any questions you have concerning your medical condition. You can search this site or the web for topics of interest that I may have written (use Dr Simone and topic).
“We provide truthful information without emotion or influence from the medical establishment, pharmaceutical industry, national organizations, special interest groups or government agencies.” Charles B Simone, M.MS., M.D.
VITAMIN C PLUS CHEMOTHERAPY DOUBLES SURVIVAL in METASTATIC PANCREATIC CANCER
Lawrenceville, NJ – Dr Simone – Published in November 2024 in Redox Biology, a randomized, phase 2 clinical trial involving 34 patients with stage 4 metastatic pancreatic cancer received either standard chemotherapy (gemcitabine and nab-paclitaxel), or the chemotherapy plus intravenous infusions of high-dose vitamin C of 75 grams three times weekly. The results showed that average overall survival was 16 months for the patients receiving the chemotherapy plus vitamin C, compared to eight months for the patients getting just chemotherapy. In addition, progression free survival was extended from four months to six months. Patients felt better with the vitamin C, had have fewer side effects, and were able to tolerate more treatment. https://www.sciencedirect.com/science/article/pii/S2213231724003537
The results of another University of Iowa phase 2 clinical trial in patients with glioblastoma, a deadly form of brain cancer, were published. That study also showed a significant increase in survival when high-dose, IV vitamin C was added to standard of care chemotherapy and radiation (published online March 30, 2024 in the journal Cancer Cell).
For twenty years, Cullen, Allen, and their associates have been investigating the potential anti-cancer effects of high-dose intravenous vitamin C. They showed that administering vitamin C intravenously (IV) results in elevated blood levels that are not possible with oral vitamin C. Cancer cells are altered by the high concentration, making them more susceptible to radiation and chemotherapy.
Refer also to:
ANTIOXIDANTS AND OTHER NUTRIENTS DO NOT INTERFERE WITH CHEMOTHERAPY OR RADIATION, AND CAN INCREASE KILL, DECREASE SIDE EFFECTS, AND INCREASE SURVIVAL
